What are the guidelines for using Doxepin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for Using Doxepin

Doxepin is indicated for the treatment of psychoneurotic patients with depression and/or anxiety, depression associated with alcoholism, depression associated with organic disease, and psychotic depressive disorders with associated anxiety, with dosing typically starting at lower doses (10-25mg) and titrating up as needed. 1

Indications and Dosing

Depression and Anxiety

  • Initial dose: 10-25mg orally at bedtime
  • Maintenance dose: 75-150mg daily
  • Maximum dose: Up to 300mg daily in severe cases
  • Therapeutic plasma concentration range: 130-150 ng/mL 2

Sleep Maintenance Insomnia

  • Low-dose doxepin (3-6mg) is effective for sleep maintenance insomnia 3
  • Lower doses are particularly effective for elderly patients

Administration Considerations

  • Administer as a single dose at bedtime to minimize daytime sedation
  • For higher doses (>150mg), consider divided dosing
  • Titrate slowly to minimize side effects, particularly in elderly patients
  • Steady-state plasma concentrations at 250mg daily: 130±113 ng/mL (parent compound) and 132±94 ng/mL (metabolite) 2

Contraindications

  • Hypersensitivity to doxepin or other dibenzoxepines
  • Glaucoma
  • Urinary retention or tendency toward urinary retention
  • Concurrent use with MAO inhibitors 1

Special Populations

Elderly Patients

  • Start with lower doses (10-25mg)
  • Titrate more slowly
  • Monitor closely for anticholinergic side effects and orthostatic hypotension

Renal Impairment

  • Reduce dose by 50% in moderate renal impairment (creatinine clearance 10-20 mL/min)
  • Avoid in severe renal impairment (creatinine clearance <10 mL/min) 2

Hepatic Impairment

  • Use with caution; dose reduction may be necessary
  • Monitor plasma levels if available

Pregnancy

  • Best to avoid during pregnancy, especially in the first trimester
  • No specific teratogenic effects have been demonstrated, but caution is advised 2

Drug Interactions

  • Avoid concurrent use with drugs that inhibit hepatic metabolism via cytochrome P450
  • Caution with macrolide antibiotics and imidazole antifungals
  • Avoid combination with drugs having arrhythmogenic properties (e.g., tricyclic antidepressants) 2
  • At doses above 150mg daily, may block the antihypertensive effect of guanethidine and related compounds 1

Side Effects and Monitoring

Common Side Effects

  • Dry mouth
  • Drowsiness
  • Constipation
  • Blurred vision
  • Orthostatic hypotension (less common than with other tricyclics) 4

Cardiovascular Effects

  • Monitor for QT prolongation
  • Use with caution in patients with preexisting cardiovascular disease
  • Despite common belief, doxepin does not appear to have a better cardiovascular safety profile than other tricyclics in patients with heart disease 5
  • ECG monitoring recommended for patients with cardiac disease

Neurological Effects

  • Monitor for confusion, ataxia, and seizures, especially with high doses or in patients with reduced drug metabolism 6

Clinical Pearls

  • The sedative properties of doxepin make it particularly useful for depressed patients with sleep disturbances 4
  • Low-dose doxepin (3-6mg) has selective H1 antagonism and is effective for insomnia with minimal effects on sleep architecture 7
  • Consider pharmacogenomic testing for CYP2D6 and CYP2C19 in cases of unexpected toxicity or poor response 6
  • In patients with detrusor overactivity, doxepin may help reduce nighttime micturition frequency and incontinence episodes 8

Monitoring Parameters

  • Baseline and periodic:
    • Mental status evaluation
    • Blood pressure (sitting and standing)
    • ECG in patients with cardiovascular disease or over 40 years old
    • Liver and renal function tests

Discontinuation

  • Taper gradually to avoid withdrawal symptoms
  • Monitor for emergence or worsening of depression during discontinuation
  • Watch for suicidal ideation, especially in younger patients 1

Doxepin combines antidepressant activity with sedative effects, making it particularly useful for patients with depression accompanied by anxiety or sleep disturbances. While it may cause fewer cardiovascular side effects at therapeutic doses compared to other tricyclics, it still requires careful monitoring, especially in patients with heart disease.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cognitive Behavioral Therapy for Insomnia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Is doxepin a safer tricyclic for the heart?

The Journal of clinical psychiatry, 1991

Research

Chronic Doxepin Toxicity Masquerading as Epilepsy in a 10-Year-Old Boy.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.